Results 31 to 40 of about 36,012 (161)

Development of allosteric modulators of GPCRs for treatment of CNS disorders

open access: yesNeurobiology of Disease, 2014
The discovery of allosteric modulators of G protein-coupled receptors (GPCRs) provides a promising new strategy with potential for developing novel treatments for a variety of central nervous system (CNS) disorders.
Hilary Highfield Nickols   +1 more
doaj   +1 more source

Allosteric Modulators: A Side Door [PDF]

open access: yesJournal of Medicinal Chemistry, 2015
Allosteric modulators of the cannabinoid CB1 receptor were first discovered in 2005. Since then, although both negative and positive allosteric modulators have been uncovered, many questions remain about their site(s) of action, as well as the basis of their signaling.
openaire   +2 more sources

Positive allosteric adenosine A2A receptor modulation suppresses insomnia associated with mania- and schizophrenia-like behaviors in mice

open access: yesFrontiers in Pharmacology, 2023
Background: Insomnia is associated with psychiatric illnesses such as bipolar disorder or schizophrenia. Treating insomnia improves psychotic symptoms severity, quality of life, and functional outcomes.
Yang Lin   +16 more
doaj   +1 more source

Analysis of positive and negative allosteric modulation in metabotropic glutamate receptors 4 and 5 with a dual ligand

open access: yesScientific Reports, 2017
As class C GPCRs and regulators of synaptic activity, human metabotropic glutamate receptors (mGluRs) 4 and 5 are prime targets for allosteric modulation, with mGlu5 inhibition or mGlu4 stimulation potentially treating conditions like chronic pain and ...
James A. R. Dalton   +2 more
doaj   +1 more source

Mapping the Interface of a GPCR Dimer: A Structural Model of the A2A Adenosine and D2 Dopamine Receptor Heteromer

open access: yesFrontiers in Pharmacology, 2018
The A2A adenosine (A2AR) and D2 dopamine (D2R) receptors form oligomers in the cell membrane and allosteric interactions across the A2AR–D2R heteromer represent a target for development of drugs against central nervous system disorders.
Dasiel O. Borroto-Escuela   +8 more
doaj   +1 more source

Allosteric Modulation of the CB1 Cannabinoid Receptor by Cannabidiol—A Molecular Modeling Study of the N-Terminal Domain and the Allosteric-Orthosteric Coupling

open access: yesMolecules, 2021
The CB1 cannabinoid receptor (CB1R) contains one of the longest N termini among class A G protein-coupled receptors. Mutagenesis studies suggest that the allosteric binding site of cannabidiol (CBD) involves residues from the N terminal domain.
Jakub Jakowiecki   +5 more
doaj   +1 more source

Molecular sites for the positive allosteric modulation of glycine receptors by endocannabinoids.

open access: yesPLoS ONE, 2011
Glycine receptors (GlyRs) are transmitter-gated anion channels of the Cys-loop superfamily which mediate synaptic inhibition at spinal and selected supraspinal sites.
Gonzalo E Yévenes   +1 more
doaj   +1 more source

Allosteric modulation of G protein-coupled receptor signaling

open access: yesFrontiers in Endocrinology, 2023
G protein-coupled receptors (GPCRs), the largest family of transmembrane proteins, regulate a wide array of physiological processes in response to extracellular signals. Although these receptors have proven to be the most successful class of drug targets,
Siyuan Shen   +6 more
doaj   +1 more source

Allosteric Modulation of Muscarinic Acetylcholine Receptors [PDF]

open access: yesCurrent Neuropharmacology, 2007
Muscarinic acetylcholine receptors (mAChRs) are prototypical Family A G protein coupled-receptors. The five mAChR subtypes are widespread throughout the periphery and the central nervous system and, accordingly, are widely involved in a variety of both physiological and pathophysiological processes.
Gregory, Karen J   +2 more
openaire   +2 more sources

The chemical diversity and structure-based discovery of allosteric modulators for the PIF-pocket of protein kinase PDK1

open access: yesJournal of Enzyme Inhibition and Medicinal Chemistry, 2019
Phosphoinositide-dependent protein kinase-1 (PDK1) is an important protein in mediating the PI3K-AKT pathway and is thus identified as a promising target.
Xinyuan Xu   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy